ImmunoGen Price on November 30, 2024
IMGNDelisted Stock | USD 18.20 0.81 4.26% |
If you're considering investing in ImmunoGen Stock, it is important to understand the factors that can impact its price. As of today, the current price of ImmunoGen stands at 18.20, as last reported on the 30th of November, with the highest price reaching 19.01 and the lowest price hitting 16.94 during the day. We have found thirty technical indicators for ImmunoGen, which you can use to evaluate the volatility of the firm. Please check out ImmunoGen's Downside Deviation of 2.71, market risk adjusted performance of 1.45, and Risk Adjusted Performance of 0.1443 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
ImmunoGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
ImmunoGen |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
IMGN |
Based on monthly moving average ImmunoGen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ImmunoGen by adding ImmunoGen to a well-diversified portfolio.
Related Headline
TG Therapeutics Headline on 29th of November 2024
TG Therapeutics to Participate in the Evercore HealthCONx Co... by gurufocus.com
Fireside chat scheduled for Tuesday, December 3, 2024, at 1000 AM ET NEW YORK, Nov. 29, 2024 -- TG Therapeutics, Inc. today announ
ImmunoGen Valuation on November 30, 2024
It is possible to determine the worth of ImmunoGen on a given historical date. On November 30, 2024 ImmunoGen was worth 19.01 at the beginning of the trading date compared to the closed value of 18.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ImmunoGen stock. Still, in general, we apply an absolute valuation method to find ImmunoGen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ImmunoGen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ImmunoGen's related companies.
Open | High | Low | Close | Volume | |
11/30/2024 | 19.01 | 19.01 | 16.94 | 18.20 | 0.00 |
Backtest ImmunoGen | | | ImmunoGen History | | | ImmunoGen Valuation |
ImmunoGen Trading Date Momentum on November 30, 2024
ImmunoGen Fundamentals Correlations and Trends
By evaluating ImmunoGen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ImmunoGen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ImmunoGen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ImmunoGen Stock history
ImmunoGen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ImmunoGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ImmunoGen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ImmunoGen stock prices may prove useful in developing a viable investing in ImmunoGen
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate therapies to treat cancer. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts. Immunogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 106 people.
ImmunoGen Stock Technical Analysis
ImmunoGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
ImmunoGen Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
ImmunoGen cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ImmunoGen November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how ImmunoGen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ImmunoGen shares will generate the highest return on investment. By undertsting and applying ImmunoGen stock market strength indicators, traders can identify ImmunoGen entry and exit signals to maximize returns
ImmunoGen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ImmunoGen's price direction in advance. Along with the technical and fundamental analysis of ImmunoGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ImmunoGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1443 | |||
Jensen Alpha | 2.74 | |||
Total Risk Alpha | 0.1504 | |||
Sortino Ratio | 1.06 | |||
Treynor Ratio | 1.44 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in ImmunoGen Stock
If you are still planning to invest in ImmunoGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoGen's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |